Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008:1032–1087. doi: 10.1007/978-0-387-68792-6_28

Pulmonary Vascular Disease

Steve D Groshong 7, Joseph F Tomashefski Jr 8,9, Carlyne D Cool 7
Editors: Joseph F Tomashefski Jr1,2, Philip T Cagle3,4, Carol F Farver5, Armando E Fraire6
PMCID: PMC7120700

Abstract

The pulmonary vasculature is an anatomic compartment that is frequently overlooked in the histologic review of lung biopsy samples, other than those obtained specifically to assess pulmonary vascular disease.1 Though often of a nonspecific nature, the histologic pattern of vascular remodeling may at times suggest its underlying pathogenesis and provide clues to the cause of pulmonary hypertension.2 Disproportionately severe vascular pathology may further indicate alternate disease processes, such as congestive heart failure or thromboemboli, contributing to the patient’s overall respiratory condition.

Keywords: Pulmonary Artery, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Bronchial Artery, Primary Pulmonary Hypertension

References

  • 1.Wagenvoort C.A. Lung biopsy specimens in the evaluation of pulmonary vascular disease. Chest. 1980;77:614–625. doi: 10.1378/chest.77.5.614. [DOI] [PubMed] [Google Scholar]
  • 2.Wagenvoort C.A. Classifying pulmonary vascular disease. Chest. 1973;64:503–504. doi: 10.1378/chest.64.4.503. [DOI] [PubMed] [Google Scholar]
  • 3.Newman J.H. Pulmonary hypertension. Am J Respir Crit Care Med. 2005;172:1072–1077. doi: 10.1164/rccm.200505-684OE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Heath D., Edwards J.E. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533–547. doi: 10.1161/01.CIR.18.4.533. [DOI] [PubMed] [Google Scholar]
  • 5.Simonneau G., Galie N.L., Rubin J., et al. Third World Symposium on Pulmonary Arterial Hypertension in Venice (June 23–25, 2003). Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12S. doi: 10.1016/j.jacc.2004.02.037. [DOI] [PubMed] [Google Scholar]
  • 6.Larsen W.J. Human embryology. 3rd ed. Philadelphia: Churchill Livingstone; 2001. pp. 201–204. [Google Scholar]
  • 7.Tomashefski J.F., Jr, Richmond B. Lung development. In: Carlo W.A., Chatburn R.L., editors. Neonatal respiratory care. 2nd ed. Chicago: Year Book Medical Publishers; 1988. pp. 1–39. [Google Scholar]
  • 8.Rossi R.N., Hislop A., Anderson R.H., et al. Systemic-to-pulmonary blood supply in tetralogy of Fallot with pulmonary atresia. Cardiol Young. 2002;12:373–388. doi: 10.1017/S1047951100012981. [DOI] [PubMed] [Google Scholar]
  • 9.Larsen W.J. Human embryology. 3rd ed. Philadelphia: Churchill Livingstone; 2001. pp. 167–169. [Google Scholar]
  • 10.Boyden E.A. The developing bronchial arteries in a fetus of the twelfth week. Am J Anat. 1970;129:357–368. doi: 10.1002/aja.1001290307. [DOI] [PubMed] [Google Scholar]
  • 11.Hislop A., Reid L. Growth and development of the respiratory system—anatomical development. In: Davis J.A., Dobbing J., editors. Scientific foundations of paediatrics. 2nd ed. London: Wm. Heinemann Medical Books; 1981. pp. 214–254. [Google Scholar]
  • 12.Wagenvoort C.A., Wagenvoort N. Pulmonary hypertension in congenital malformation of pulmonary vessels. In: Wagenvoort C.A., Wagenvoort N., Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 291–310. [Google Scholar]
  • 13.Pool P.E., Vogel J.H.K., Blount S.G. Congenital unilateral absence of a pulmonary artery. The importance of flow in pulmonary hypertension. Am J Cardiol. 1962;10:796–732. doi: 10.1016/0002-9149(62)90248-5. [DOI] [PubMed] [Google Scholar]
  • 14.Bahler R.C., Carson P., Traks E., et al. Absent right pulmonary artery. Am J Med. 1969;46:64–71. doi: 10.1016/0002-9343(69)90058-8. [DOI] [PubMed] [Google Scholar]
  • 15.Kochiadekis G.E., Chrysostomakis S.I., Igoumenidis N.E., et al. Anomalous collateral from the coronary artery to the affected lung in a case of congential absence of the left pulmonary artery. Effect on coronary circulation. Chest. 2002;121:2063–2066. doi: 10.1378/chest.121.6.2063. [DOI] [PubMed] [Google Scholar]
  • 16.Moser K.M., Olson L.K., Schlusselbert M., et al. Chronic thromboembolic occlusion in the adult can mimic pulmonary artery agenesis. Chest. 1989;95:503–508. doi: 10.1378/chest.95.3.503. [DOI] [PubMed] [Google Scholar]
  • 17.Tabakin B.S., Hanson J.S., Adhikari P.K., et al. Physiologic studies in congenital absence of the left main pulmonary artery. Circulation. 1960;22:1107–1111. doi: 10.1161/01.CIR.22.6.1107. [DOI] [PubMed] [Google Scholar]
  • 18.Ko T., Gatz M.G., Reisz G.R. Congenital unilateral absence of a pulmonary artery: a report of two adult cases. Am Rev Respir Dis. 1990;141:795–798. doi: 10.1164/ajrccm/141.3.795. [DOI] [PubMed] [Google Scholar]
  • 19.Madoff I.M., Gaensler E.A., Strieder J.W. Congenital absence of the right pulmonary artery. N Engl J Med. 1952;247:149–157. doi: 10.1056/NEJM195207312470501. [DOI] [PubMed] [Google Scholar]
  • 20.Subramanian R., Virmani R. Pathology of the pulmonary circulation before and after correction of low flow states. In: Saldana M.J., editor. Pathology of pulmonary disease. Philadelphia: JB Lippincott; 1994. pp. 261–271. [Google Scholar]
  • 21.Wagenvoort C.A., Nauta J., van der Scaar P.J., et al. Vascular changes in pulmonic stenosis and tetralogy of Fallot studied in lung biopsies. Circulation. 1967;36:924–932. doi: 10.1161/01.CIR.36.6.924. [DOI] [PubMed] [Google Scholar]
  • 22.Wagenvoort C.A., Edwards J.E. The pulmonary arterial tree in pulmonic atresia. Arch Pathol. 1961;71:646–653. [Google Scholar]
  • 23.Rich A.R. A hitherto unrecognized tendency to the development of widespread pulmonary vascular obstruction in patients with congenital pulmonary stenosis (tetralogy of Fallot) Bull Johns Hopkins Hosp. 1948;82:389–402. [PubMed] [Google Scholar]
  • 24.Heath D., DuShane J.W., Wood E.H., et al. The aetiology of pulmonary thrombosis in cyanotic congenital heart disease with pulmonary stenosis. Thorax. 1958;12:213–217. doi: 10.1136/thx.13.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hales M.R., Liebow A.A. Collateral circulation to the lungs in congenital pulmonic stenosis. Bull Int Assoc Med Museums. 1948;28:1–22. [Google Scholar]
  • 26.Wagenvoort C.A., Wagenvoort N. Postoperative pulmonary hypertension in tetralogy of Fallot. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. Philadelphia: John Wiley & Sons; 1977. pp. 311–322. [Google Scholar]
  • 27.Wagenvoort C.A. Medial defects of lung vessels: a new cause of pulmonary hypertension. Hum Pathol. 1986;17:722–726. doi: 10.1016/S0046-8177(86)80181-2. [DOI] [PubMed] [Google Scholar]
  • 28.Wagenvoort C.A. Misalignment of lung vessels: a syndrome causing persistent neonatal pulmonary hypertension. Hum Pathol. 1986;17:727–730. doi: 10.1016/S0046-8177(86)80182-4. [DOI] [PubMed] [Google Scholar]
  • 29.Parker T.A., Ivy D.D., Kinsella J.P., et al. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia. Am J Respir Crit Care Med. 1997;155:743–746. doi: 10.1164/ajrccm.155.2.9032222. [DOI] [PubMed] [Google Scholar]
  • 30.Janney C.G., Askin F.B., Kuhn C., III Congenital alveolar capillary dysplasia—an unusual cause of respiratory distress in the newborn. Am J Clin Pathol. 1981;76:722–727. doi: 10.1093/ajcp/76.5.722. [DOI] [PubMed] [Google Scholar]
  • 31.Cater G., Thibeault D.W., Beatty E.C., Jr, et al. Misalignment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension. J Pediatr. 1989;114:293–300. doi: 10.1016/S0022-3476(89)80800-5. [DOI] [PubMed] [Google Scholar]
  • 32.Khorsand J., Tennant R., Gillies C., et al. Congenital alveolar capillary dysplasia: a developmental vascular anomaly causing persistent pulmonary hypertension of the newborn. Pediatr Pathol. 1985;3:299–306. doi: 10.3109/15513818509078790. [DOI] [PubMed] [Google Scholar]
  • 33.Cullinane C., Cox P.N., Silver M.M. Persistent pulmonary hypertension of the newborn due to alveolar capillary dysplasia. Pediatr Pathol. 1992;12:499–514. doi: 10.3109/15513819209024200. [DOI] [PubMed] [Google Scholar]
  • 34.Rabinovitch M., Haworth S.G., Vance Z., et al. Early pulmonary vascular changes in congenital heart disease studied in biopsy tissue. Hum Pathol. 1980;11:499–509. [PubMed] [Google Scholar]
  • 35.Wagenvort C.A., Wagenvoort N. Normal pulmonary and bronchial vasculature. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 17–55. [Google Scholar]
  • 36.Wagenvoort C.A., Wagenvoort N. Pulmonary hypertension in left to right cardiac shunts. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 56–94. [Google Scholar]
  • 37.Hatano S., Strasser T. Primary pulmonary hypertension. Geneva, Switzerland: World Health Organization; 1975. pp. 1–46. [Google Scholar]
  • 38.Drut R. Pulmonary hypertension in congenital heart disease. In: Saldana M.J., editor. Pathology of pulmonary disease. Philadelphia: JB Lippincott; 1994. pp. 217–223. [Google Scholar]
  • 39.Virmani R., Roberts W.C. Pulmonary arteries in congential heart disease: A structure-function analysis. In: Roberts W.C., editor. Adult congenital heart disease. Philadelphia: FA Davis; 1987. pp. 455–499. [PubMed] [Google Scholar]
  • 40.Wagenvoort C.A., DuShane J.W., Edwards J.E. Hypertensive pulmonary arterial lesions as a late result of anastomosis of systemic and pulmonary circulations. Mayo Clin Proc. 1960;35:186–191. [PubMed] [Google Scholar]
  • 41.Hofschire P.J., Rosenquist G.C., Ruckerman R.N., et al. Pulmonary vascular disease complicating the Blalock-Taussig anastomosis. Circulation. 1977;56:124–126. doi: 10.1161/01.CIR.56.1.124. [DOI] [PubMed] [Google Scholar]
  • 42.Newfeld E.A., Waldman J.D., Paul M.H., et al. Pulmonary vascular disease after systemic pulmonary arterial shunt operations. Am J Cardiol. 1977;39:715–20. doi: 10.1016/S0002-9149(77)80134-3. [DOI] [PubMed] [Google Scholar]
  • 43.Rich S, Rubin LJ, Abenhail L, et al. Executive summary from the World Symposium on primary pulmonary hypertension (Evian, France, September 6–10, 1998). World Health Organization publication. http://www.who.int/cardiovascular_diseases/resources/publications/en.
  • 44.Simonneau G., Galie N.L., Rubin J., et al. Third World Symposium on Pulmonary Arterial Hypertension in Venice (June 23–25, 2003). Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:4S–12S. doi: 10.1016/j.jacc.2004.02.037. [DOI] [Google Scholar]
  • 45.Zaiman A., Fijalkowska I., Hassoun P.M., et al. One hundred years of research in the pathogenesis of pulmonary hypertension. Am J Respir Cell Mol Biol. 2005;33:425–431. doi: 10.1165/rcmb.F307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rubin L.J. American College of Chest Physicians Consensus Statement. Chest. 1993;104:236–50. doi: 10.1378/chest.104.1.236. [DOI] [PubMed] [Google Scholar]
  • 47.Macnee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med. 1994;150:833–852. doi: 10.1164/ajrccm.150.3.8087359. [DOI] [PubMed] [Google Scholar]
  • 48.World Health Organization Chronic cor pulmonale. A report of the expert committee. Circulation. 1963;27:594–598. doi: 10.1161/01.CIR.27.4.594. [DOI] [Google Scholar]
  • 49.Fulton R.M., Hutchinson E.C., Jones A.M. Ventricular weight in cardiac hypertrophy. Br Heart J. 1952;14:413–420. doi: 10.1136/hrt.14.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107:216–223. doi: 10.7326/0003-4819-107-2-216. [DOI] [PubMed] [Google Scholar]
  • 51.Widlitz A., Barst R.J. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21:155–176. doi: 10.1183/09031936.03.00088302. [DOI] [PubMed] [Google Scholar]
  • 52.Greenwood R.D., Nadas A.S. The clinical course of cardiac disease in Down’s syndrome. Pediatrics. 1976;58:893–897. [PubMed] [Google Scholar]
  • 53.Chi T.P.L., Krovetz L.J. The pulmonary vascular bed in children with Down’s syndrome. J Pediatr. 1975;86:533–538. doi: 10.1016/S0022-3476(75)80142-9. [DOI] [PubMed] [Google Scholar]
  • 54.Yamaki S., Horiuchi T., Takahashi T. Pulmonary changes in congenital heart disease with Down’s syndrome: their significance as a cause of postoperative respiratory failure. Thorax. 1985;40:380–386. doi: 10.1136/thx.40.5.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Cool C.D., Pradeep R.R., Yeager M.E., et al. Expression of human herpes virus 8 in primary pulmonary hypertension. N Engl J Med. 2003;349:1113–1122. doi: 10.1056/NEJMoa035115. [DOI] [PubMed] [Google Scholar]
  • 56.Klaes R., Friedrich T., Spitkovsky D., et al. Overexpression of pl6(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276–284. doi: 10.1002/ijc.1174. [DOI] [PubMed] [Google Scholar]
  • 57.Sgonc R., Gruschwitz M.S., Dietrich H., et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996;98:785–792. doi: 10.1172/JCI118851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sullivan C.C., Du L., Chu D., et al. Induction of pulmonary hypertension by an angiopoietin l/TIE2/serotonin pathway. Proc Natl Acad Sci. 2003;100:1231–1236. doi: 10.1073/pnas.1933740100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Davie N., Haleen S.J., Upton P.D., et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med. 2002;165:398–405. doi: 10.1164/ajrccm.165.3.2104059. [DOI] [PubMed] [Google Scholar]
  • 60.Tuder R.M., Cool C.D., Yeager M., et al. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med. 2001;22:405–418. doi: 10.1016/S0272-5231(05)70280-X. [DOI] [PubMed] [Google Scholar]
  • 61.Geraci M.W., Moore M., Gesell T., et al. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res. 2001;88:555–562. doi: 10.1161/01.RES.88.6.555. [DOI] [PubMed] [Google Scholar]
  • 62.Ameshima S., Golpon H., Cool C.D., et al. Peroxisome proliferation-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res. 2003;92:1162–1169. doi: 10.1161/01.RES.0000073585.50092.14. [DOI] [PubMed] [Google Scholar]
  • 63.Fishman A.P. Changing concepts of the pulmonary plexi-form lesion. Physiol Res. 2000;49:485–492. [PubMed] [Google Scholar]
  • 64.Loyd J.E., Butler M.G., Foroud T.M., et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;152:93–97. doi: 10.1164/ajrccm.152.1.7599869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lane K.B., Machado R.D., Pauciulo M.W., et al. Heterozygous germline mutations in a TGF-beta receptor, BMPR2, are the cause of familial primary pulmonary hypertension. Nature Genet. 2000;26:81–84. doi: 10.1038/79226. [DOI] [PubMed] [Google Scholar]
  • 66.Thomson J.R., Machado R.D., Pauciulo M.W., et al. Sporadic primary pulmonary hypertension is associated with germ-line mutations of the gene encoding BMPR-II, a receptor member of the TGF family. J Med Genet. 2000;37:741–745. doi: 10.1136/jmg.37.10.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Fagan K., Badesch D.B. Pulmonary hypertension associated with connective tissue disease. Prog Cardiovasc Dis. 2002;45:225–234. doi: 10.1053/pcad.2002.129975. [DOI] [PubMed] [Google Scholar]
  • 68.Yousem S.A. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol. 1990;21:467–474. doi: 10.1016/0046-8177(90)90002-M. [DOI] [PubMed] [Google Scholar]
  • 69.Hoffman R.W., Greidinger E.L. Mixed connective tissue disease. Curr Opin Rheumatol. 2000;12:386–390. doi: 10.1097/00002281-200009000-00006. [DOI] [PubMed] [Google Scholar]
  • 70.Pan T.L., Thumboo J., Boey M.L. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus. 2000;9:338–342. doi: 10.1191/096120300678828361. [DOI] [PubMed] [Google Scholar]
  • 71.Hoeper M.M. Pulmonary hypertension in collagen vascular disease. Eur Respir J. 2002;19:571–576. doi: 10.1183/09031936.02.01512001. [DOI] [PubMed] [Google Scholar]
  • 72.Cool C.D., Kennedy D., Voekel N.F., et al. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infections. Hum Pathol. 1997;28:434–442. doi: 10.1016/S0046-8177(97)90032-0. [DOI] [PubMed] [Google Scholar]
  • 73.Eddahibi S., Humbert M., Sediame S., et al. Imbalance between platelet vascular endothelial growth factor and platelet derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med. 2000;162:1493–1499. doi: 10.1164/ajrccm.162.4.2003124. [DOI] [PubMed] [Google Scholar]
  • 74.Voelkel N.F., Hoeper M., Maloney J., et al. Vascular endothelial growth factor in pulmonary hypertension. Ann NY Acad Sci. 1996;796:186–193. doi: 10.1111/j.1749-6632.1996.tb32580.x. [DOI] [PubMed] [Google Scholar]
  • 75.Hoeper M.M., Sosada M., Fabel H. Plasma coagulation profiles in patients with severe primary pulmonary hypertension. Eur Respir J. 1998;12:1446–1449. doi: 10.1183/09031936.98.12061446. [DOI] [PubMed] [Google Scholar]
  • 76.Welsh C.H., Hassell K.L., Badesch D.B., et al. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest. 1996;110:710–717. doi: 10.1378/chest.110.3.710. [DOI] [PubMed] [Google Scholar]
  • 77.Budhiraja R., Hassoun P.M. Portopulmonary hypertension: a tale of two circulations. Chest. 2003;123:562–576. doi: 10.1378/chest.123.2.562. [DOI] [PubMed] [Google Scholar]
  • 78.McDonnell P.J., Toye P.A., Hutchins G.M. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis. 1983;127:437–441. doi: 10.1164/arrd.1983.127.4.437. [DOI] [PubMed] [Google Scholar]
  • 79.Hadengue A., Benhayoun M.K., Lebrec D., et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100:520–528. doi: 10.1016/0016-5085(91)90225-a. [DOI] [PubMed] [Google Scholar]
  • 80.Kuddus R.H., Nalesnik M.A., Subbotin V.M., et al. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes—an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J Hepatol. 2000;33:725–732. doi: 10.1016/S0168-8278(00)80302-5. [DOI] [PubMed] [Google Scholar]
  • 81.Gandhi C.R., Kang Y., De Wolf A., et al. Altered endothelin homeostasis in patients undergoing liver transplantation. Liver Transplant Surg. 1996;2:362–369. doi: 10.1002/lt.500020506. [DOI] [PubMed] [Google Scholar]
  • 82.Speich R., Jenni R., Opravil M., et al. Primary pulmonary hypertension in HIV infection. Chest. 1991;100:1268–1271. doi: 10.1378/chest.100.5.1268. [DOI] [PubMed] [Google Scholar]
  • 83.Mesa R.A., Edell E.S., Dunn W.F., et al. Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc. 1998;73:37–45. doi: 10.1016/S0025-6196(11)63616-1. [DOI] [PubMed] [Google Scholar]
  • 84.Pellicelli A.M., Barbaro G., Palmieri F., et al. Primary pulmonary hypertension in HIV patients: a systematic review. Angiology. 2001;52:31–41. doi: 10.1177/000331970105200105. [DOI] [PubMed] [Google Scholar]
  • 85.Mette S.A., Palevsky H., Pietra G.G., et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of pulmonary arteriopathy. Am Rev Respir Dis. 1992;145:1196–1200. doi: 10.1164/ajrccm/145.5.1196. [DOI] [PubMed] [Google Scholar]
  • 86.Humbert M., Monti G., Fartoukh M., et al. Platelet derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J. 1998;11:554–559. [PubMed] [Google Scholar]
  • 87.Ehrenreich H., Riechmann P., Sinowatz F., et al. Potent stimulation of monocyte endothelin-1 production by HIV-1 glycoprotein. J Immunol. 1993;150:4601–4609. [PubMed] [Google Scholar]
  • 88.Giaid A., Yanagisawa M., Langleben D. Expression of endothelin-1 in lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732–1739. doi: 10.1056/NEJM199306173282402. [DOI] [PubMed] [Google Scholar]
  • 89.Morse J.H., Barst R.J., Itescu S., et al. Primary pulmonary hypertension in HIV infection. An outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med. 1996;153:1299–1301. doi: 10.1164/ajrccm.153.4.8616557. [DOI] [PubMed] [Google Scholar]
  • 90.Connolly H.M., Crary J.L., McGoon M.D., et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581–588. doi: 10.1056/NEJM199708283370901. [DOI] [PubMed] [Google Scholar]
  • 91.Fishman A.P. Aminorex to fen/phen. An epidemic foretold. Circulation. 1999;99:156–161. doi: 10.1161/01.CIR.99.1.156. [DOI] [PubMed] [Google Scholar]
  • 92.Mark E.J., Patalas E.D., Chang H.T., et al. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med. 1997;337:602–606. doi: 10.1056/NEJM199708283370904. [DOI] [PubMed] [Google Scholar]
  • 93.Tomita T., Zhao Q. Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine. Chest. 2002;121:649–652. doi: 10.1378/chest.121.2.649. [DOI] [PubMed] [Google Scholar]
  • 94.Strother J., Fedullo P., Yi E.S., et al. Complex vascular lesions at autopsy in a patient with phentermine-fenfluramine use and rapidly progressing pulmonary hypertension. Arch Pathol Lab Med. 1999;123:539–540. doi: 10.5858/1999-123-0539-CVLAAI. [DOI] [PubMed] [Google Scholar]
  • 95.Rothman R.B., Ayestas M.A., Dersch C.M., et al. Fenfluramine and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation. 1999;100:869–875. doi: 10.1161/01.CIR.100.8.869. [DOI] [PubMed] [Google Scholar]
  • 96.Eddahibi S., Humbert M., Fadel E., et al. Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension. Chest. 2002;121(suppl):97S–98S. [PubMed] [Google Scholar]
  • 97.Kay J.M., Smith P., Heath D. Aminorex and the pulmonary circulation. Thorax. 1971;26:262–270. doi: 10.1136/thx.26.3.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Gurtner H.P. Aminorex and pulmonary hypertension: a review. Cor Vasa. 1985;27:160–171. [PubMed] [Google Scholar]
  • 99.Kramer M.S., Lane D.A. Aminorex, Dexfenfluramine and primary pulmonary hypertension. J Clin Epidemiol. 1998;51:361–364. doi: 10.1016/S0895-4356(97)00289-8. [DOI] [PubMed] [Google Scholar]
  • 100.Sanchez-Porro V.P., Posada de la Paz M., de Andres C.P., et al. Toxic oil syndrome: survival in the whole cohort between 1981 and 1995. J Clin Epidemiol. 2003;56:701–708. doi: 10.1016/S0895-4356(03)00119-7. [DOI] [PubMed] [Google Scholar]
  • 101.Gomez-Sanchez M.A., Saenz de la Calzada C., Gomez-Pajuelo C., et al. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome. J Am Coll Cardiol. 1991;18:1539–1545. doi: 10.1016/0735-1097(91)90688-6. [DOI] [PubMed] [Google Scholar]
  • 102.Garcia-Dorado D., Miller D.D., Garcia E.J., et al. An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain. J Am Coll Cardiol. 1983;10:1216–1222. doi: 10.1016/S0735-1097(83)80133-8. [DOI] [PubMed] [Google Scholar]
  • 103.Murray R., Smialek J., Golle M., et al. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest. 1989;96:1050–1053. doi: 10.1378/chest.96.5.1050. [DOI] [PubMed] [Google Scholar]
  • 104.Schaiberger P., Kennedy T., Miller F., et al. Pulmonary hypertension associated with long-term inhalation of ‘crank’ methamphetamine. Chest. 1993;104:614–616. doi: 10.1378/chest.104.2.614. [DOI] [PubMed] [Google Scholar]
  • 105.Robertson C., Reynolds R., Wilson J. Pulmonary hypertension and foreign body granulomas in intravenous drug users. Am J Med. 1976;61:657–664. doi: 10.1016/0002-9343(76)90144-3. [DOI] [PubMed] [Google Scholar]
  • 106.Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988;17:1243–1247. doi: 10.1016/S0196-0644(88)80078-7. [DOI] [PubMed] [Google Scholar]
  • 107.Katz A., Hoffman R., Silverman R. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med. 1993;22:1485–1487. doi: 10.1016/S0196-0644(05)82002-5. [DOI] [PubMed] [Google Scholar]
  • 108.Murray R., Smialek J., Golle M., et al. Pulmonary vascular abnormalities in cocaine users. Am Rev Respir Dis (Suppl) 1988;137:459. [Google Scholar]
  • 109.Yakovlevitch M., Siegal M., Hoch D.H., et al. Pulmonary hypertension in a patient with tryptophan-induced eosinophilia-myalgia syndrome. Am J Med. 1991;90:272–273. [PubMed] [Google Scholar]
  • 110.Tazelaar H.D., Myers J.L., Drage C.W., et al. Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features. Chest. 1990;97:1032–1036. doi: 10.1378/chest.97.5.1032. [DOI] [PubMed] [Google Scholar]
  • 111.Catton C.K., Elmer J.C., Whitehouse A.C., et al. Pulmonary involvement in the eosinophilia-myalgia syndrome. Chest. 1991;99:327–329. doi: 10.1378/chest.99.2.327. [DOI] [PubMed] [Google Scholar]
  • 112.Kernan W.N., Viscoli C.M., Brass L.M., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826–1832. doi: 10.1056/NEJM200012213432501. [DOI] [PubMed] [Google Scholar]
  • 113.Barst R.J., Abenhaim L. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure. Heart. 2004;90:e42. doi: 10.1136/hrt.2004.036491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Wagenvoort C.A., Wagenvoort N., Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 21–23. [Google Scholar]
  • 115.Heath D., Wood E.H., DuShane J.W., et al. The structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis. J Pathol Bacteriol. 1959;77:443–456. doi: 10.1002/path.1700770216. [DOI] [PubMed] [Google Scholar]
  • 116.Saldana M., Arias-Stella J. Studies on the structure of the pulmonary trunk. I. Normal changes in the elastic configuration of the human pulmonary trunk at different ages. Circulation. 1963;27:1086–1093. doi: 10.1161/01.CIR.27.6.1086. [DOI] [PubMed] [Google Scholar]
  • 117.Oppenheimer E.G., Esterly J.R. Medial mucoid lesions of the pulmonary artery in cystic fibrosis, pulmonary hypertension, and other disorders. Lab Invest. 1974;30:411–416. [PubMed] [Google Scholar]
  • 118.Heath D., Wood E.G., DuShane J.W., et al. The relation of age and blood pressure to atheroma in the pulmonary arteries and thoracic aorta in congenital heart disease. Lab Invest. 1960;9:259–272. [PubMed] [Google Scholar]
  • 119.Moore G.W., Smith R.R.L., Hutchins G.M. Pulmonary artery atherosclerosis. Correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease. Arch Pathol Lab Med. 1982;106:378–380. [PubMed] [Google Scholar]
  • 120.Vanek J. Fibrous bands and networks of postembolic origin in the pulmonary arteries. J Pathol Bacteriol. 1961;81:537–539. doi: 10.1002/path.1700810230. [DOI] [PubMed] [Google Scholar]
  • 121.Wagenvoort C.A., Wagenvoort N. Hypoxic pulmonary hypertension. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 232–259. [Google Scholar]
  • 122.Wagenvoort C.A., Mooi W.J. Biopsy pathology of the pulmonary vasculature. London: Chapman and Hall; 1989. [Google Scholar]
  • 123.Cool C.D., Stewart J.S., Werahera P., et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol. 1999;155:411–419. doi: 10.1016/S0002-9440(10)65137-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.D’Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343–349. doi: 10.7326/0003-4819-115-5-343. [DOI] [PubMed] [Google Scholar]
  • 125.Rubin L.J. Primary pulmonary hypertension. N Engl J Med. 1997;336:111–117. doi: 10.1056/NEJM199701093360207. [DOI] [PubMed] [Google Scholar]
  • 126.Rich S., Kaufmann E., Levy P.S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76–81. doi: 10.1056/NEJM199207093270203. [DOI] [PubMed] [Google Scholar]
  • 127.Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296–302. doi: 10.1056/NEJM199602013340504. [DOI] [PubMed] [Google Scholar]
  • 128.Annual report of the U. S. scientific registry of transplant recipients and the organ procurement and transplantation network. Bethesda, MD: U.S. Dept. of Health and Human Services, Health Resources and Services Administration, Bureau of Health Resources Development, Division of Transplantation, 1997:186.
  • 129.Mariette X., Brenot F., Brouet J.C. Recovery from pulmonary hypertension with steroid therapy in a patient with Sjogren’s syndrome and polymyositis. J Rheumatol. 1994;21:772–773. [PubMed] [Google Scholar]
  • 130.Speich R., Jenni R., Opravil M., Jaccard R. Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy. Swiss Med Wkly. 2001;131:663–665. doi: 10.4414/smw.2001.09842. [DOI] [PubMed] [Google Scholar]
  • 131.Pellicelli A.M., Palmieri F., D’Ambrosio C., et al. Role of human immunodeficiency virus in primary pulmonary hypertension-case reports. Angiology. 1998;49:1005–1011. doi: 10.1177/000331979804901206. [DOI] [PubMed] [Google Scholar]
  • 132.Deterling R.A., Jr, Clagett O.T. Aneurysm of the pulmonary artery: review of the literature and report of a case. Am Heart J. 1947;34:471–498. doi: 10.1016/0002-8703(47)90527-9. [DOI] [PubMed] [Google Scholar]
  • 133.Bartter T., Irwin R.S., Nash G. Aneurysms of the pulmonary arteries. Chest. 1988;94:1065–1075. doi: 10.1378/chest.94.5.1065. [DOI] [PubMed] [Google Scholar]
  • 134.Charlton R.W., DePlessis L.A. Multiple pulmonary artery aneurysms. Thorax. 1961;16:364–371. doi: 10.1136/thx.16.4.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Goh T.H. Mycotic aneurysm of the pulmonary artery: a report of 2 cases. Br Heart J. 1974;36:387–390. doi: 10.1136/hrt.36.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Butto F., Lucas R.V., Edwards J.E. Pulmonary arterial aneurysms. A pathological study of five cases. Chest. 1987;91:237–241. doi: 10.1378/chest.91.2.237. [DOI] [PubMed] [Google Scholar]
  • 137.Epstein S., Naji A.F. Pulmonary artery aneurysm with dissection after Blalock operation for tetralogy of Fallot. Am J Cardiol. 1960;5:560–563. doi: 10.1016/0002-9149(60)90117-X. [DOI] [PubMed] [Google Scholar]
  • 138.Navarro C., Dickenson P.C., Kondlapoodi P., et al. Mycotic aneurysms of the pulmonary arteries in intravenous drug addicts: report of three cases and review of the literature. Am J Med. 1984;76:1124–1131. doi: 10.1016/0002-9343(84)90869-6. [DOI] [PubMed] [Google Scholar]
  • 139.Barbour D.J., Roberts W.C. Aneurysm of the pulmonary trunk unassociated with intracardiac or great vessel left-to-right shunting. Am J Cardiol. 1987;59:192–194. doi: 10.1016/S0002-9149(87)80113-3. [DOI] [PubMed] [Google Scholar]
  • 140.Steurer J., Jenni R., Medici T.C., et al. Dissecting aneurysm of the pulmonary artery with pulmonary hypertension. Am Rev Respir Dis. 1990;142:1219–1221. doi: 10.1164/ajrccm/142.5.1219. [DOI] [PubMed] [Google Scholar]
  • 141.Boyd L.J., McGavack T.H. Aneurysm of the pulmonary artery: a review of the literature and report of 2 new cases. Am Heart J. 1939;18:562–587. doi: 10.1016/S0002-8703(39)90880-X. [DOI] [Google Scholar]
  • 142.Shull W.K., Kapadia S.B., Zuberbuhler J.R. Aneurysm of the main pulmonary artery. Association with patent ductus arteriosus and ostium secundum defect. Am J Dis Child. 1970;119:507–509. doi: 10.1001/archpedi.1970.02100050509010. [DOI] [PubMed] [Google Scholar]
  • 143.D’Aunoy R., von Haam E. Aneurysm of the pulmonary artery with patent ductus arteriosus (Botallo’s duct). Report of two cases and review of the literature. J Pathol. 1938;38:39–60. doi: 10.1002/path.1700380107. [DOI] [Google Scholar]
  • 144.Nguyen G.K., Dowling G.P. Dissecting aneurysm of the pulmonary trunk. Arch Pathol Lab Med. 1989;113:1178–1180. [PubMed] [Google Scholar]
  • 145.Natelson E.A., Watts H.D. Cystic medionecrosis of the pulmonary arteries. Chest. 1970;57:333–335. doi: 10.1378/chest.57.4.333. [DOI] [PubMed] [Google Scholar]
  • 146.Tung H.-L., Liebow A.A. Marfan’s syndrome: observations at necropsy with special reference to medionecrosis of the great vessels. Lab Invest. 1952;1:382–406. [PubMed] [Google Scholar]
  • 147.Dennison A.R., Watkins R.M., Bunning A.J. Simultaneous aortic and pulmonary artery aneurysms due to giant cell arteritis. Thorax. 1985;40:156–157. doi: 10.1136/thx.40.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Durieux P., Bletry O., Huchon, et al. Multiple pulmonary artery aneurysms in Behcet’s disease and Hughes-Stovin syndrome. Am J Med. 1981;71:736–741. doi: 10.1016/0002-9343(81)90245-X. [DOI] [PubMed] [Google Scholar]
  • 149.Aroussi A.A., Redai M., El Ouardi F., et al. Bilateral pulmonary artery aneurysm in Behcet syndrome: report of two operative cases. J Thorac Cardiovasc Surg. 2005;129:1170–1171. doi: 10.1016/j.jtcvs.2004.08.038. [DOI] [PubMed] [Google Scholar]
  • 150.Hughes J.P., Stovin P.G.I. Segmental pulmonary artery aneurysms with peripheral venous thrombosis. Br J Dis Chest. 1959;53:19–27. doi: 10.1016/S0007-0971(59)80106-6. [DOI] [PubMed] [Google Scholar]
  • 151.Frater R.W.M., Beck W., Schruke V. The syndrome of pulmonary artery aneurysms, pulmonary artery thrombi, and peripheral venous thrombi. J Thorac Cardiovasc Surg. 1965;49:330–338. [PubMed] [Google Scholar]
  • 152.Erkan D., Yazici Y., Sanders A., et al. Is Hughes-Stovin syndrome Behcet’s disease? Clin Experiment Rheumatol. 2004;22:S64–S68. [PubMed] [Google Scholar]
  • 153.Symbas P.N., Scott H.W. Traumatic aneurysm of the pulmonary artery. J Thorac Cardiovasc Surg. 1963;45:645–649. [PubMed] [Google Scholar]
  • 154.Saluja S., Henderson K.J., White R.I., Jr Embolotherapy in the bronchial and pulmonary circulations. Radiol Clin North A. 2000;38:425–448. doi: 10.1016/S0033-8389(05)70172-X. [DOI] [PubMed] [Google Scholar]
  • 155.Rosenow E.C., III, Osmundson P.J., Brown M.L. Pulmonary embolism. Mayo Clin Proc. 1981;56:161–178. [PubMed] [Google Scholar]
  • 156.Moser K.M. Venous thromboembolism. Am Rev Respir Dis. 1990;141:235–249. doi: 10.1164/ajrccm/141.1.235. [DOI] [PubMed] [Google Scholar]
  • 157.Goldhaber S.Z. Pulmonary embolism. Lancet. 2004;363:1295–1305. doi: 10.1016/S0140-6736(04)16004-2. [DOI] [PubMed] [Google Scholar]
  • 158.Morpurgo M., Schmid C. The spectrum of pulmonary embolism. Chest. 1995;107(suppl):18S–20S. doi: 10.1378/chest.107.1_Supplement.18S. [DOI] [PubMed] [Google Scholar]
  • 159.Tomashefski JF, Zorn S. Pulmonary embolism: a new look at an old problem. Geriatrics. 1973;September:78–82. [PubMed] [Google Scholar]
  • 160.Freeman D.G., Suyemoto J., Wessler S. Frequency of pulmonary thromboembolism in man. N Engl J Med. 1965;272:1278–1280. doi: 10.1056/NEJM196506172722406. [DOI] [PubMed] [Google Scholar]
  • 161.Havig O. Deep vein thrombosis and pulmonary embolism. Acta Chirurgica Scandinavica. 1977;478(suppl):24–37. [PubMed] [Google Scholar]
  • 162.Morrell T., Dunnill M.S. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg. 1968;55:347–352. doi: 10.1002/bjs.1800550506. [DOI] [PubMed] [Google Scholar]
  • 163.Rubinstein I., Murray D., Hoffstein V. Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med. 1988;148:1425–1426. doi: 10.1001/archinte.1988.00380060189033. [DOI] [PubMed] [Google Scholar]
  • 164.Tapson V.F., Carroll B.A., Davison B.L., et al. The diagnostic approach to acute venous thromboembolism. Am J Respir Crit Care Med. 1999;160:1043–1066. doi: 10.1164/ajrccm.160.3.16030. [DOI] [PubMed] [Google Scholar]
  • 165.Connors A.F., Castele R.J., Farhat N.Z., et al. Complications of right heart catheterization. A prospective autopsy study. Chest. 1985;88:567–572. doi: 10.1378/chest.88.4.567. [DOI] [PubMed] [Google Scholar]
  • 166.Bell W.R., Simon T.L., DeMets D.L. The clinical features of submassive and massive pulmonary emboli. Am J Med. 1977;62:355–360. doi: 10.1016/0002-9343(77)90832-4. [DOI] [PubMed] [Google Scholar]
  • 167.Stein P.D., Hull R.D., Patel K.C., et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589–602. doi: 10.7326/0003-4819-140-8-200404200-00005. [DOI] [PubMed] [Google Scholar]
  • 168.Bockenstedt P. D-Dimer in venous thromboembolism. N Engl J Med. 2003;349(13):1203–1204. doi: 10.1056/NEJMp030084. [DOI] [PubMed] [Google Scholar]
  • 169.Wagenvoort C.A. Pathology of pulmonary thromboembolism. Chest. 1995;107(suppl):10S–17S. doi: 10.1378/chest.107.1_Supplement.10S. [DOI] [PubMed] [Google Scholar]
  • 170.Wagenvoort C.A., Wagenvoort N. Embolic pulmonary hypertension. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 143–176. [Google Scholar]
  • 171.Meyer J.S. Thromboembolic pulmonary arterial necrosis and arteritis in man. Arch Pathol. 1960;70:63–72. [PubMed] [Google Scholar]
  • 172.Olsen E.G.J. Ischemic disease of the myocardium and its complications. In: Silver M.D., editor. Cardiovascular pathology. New York: Churchill Livingstone; 1983. pp. 411–112. [Google Scholar]
  • 173.Korn D., Gore I., Blenke A., et al. Pulmonary arterial bands and webs: an unrecognized manifestation of organized pulmonary emboli. Am J Pathol. 1962;40:129–151. [PMC free article] [PubMed] [Google Scholar]
  • 174.Irniger W. Histologische Altersbestimmung von Thrombosen und Embolien. Virchows Arch Pathol Anat 1963;220–237.
  • 175.Castleman B. Healed pulmonary infarcts. Arch Pathol. 1940;30:130–142. [Google Scholar]
  • 176.Ellis F.G., Grindlay J.H., Edwards J.E. The bronchial arteries. II. Their role in pulmonary embolism and infarction. Surgery. 1952;31:167–179. [PubMed] [Google Scholar]
  • 177.Schraufnagel D.E., Tsao M.S., Yao Y.T. Factors associated with pulmonary infarction. Am J Clin Pathol. 1985;84:15–18. doi: 10.1093/ajcp/84.1.15. [DOI] [PubMed] [Google Scholar]
  • 178.Dalen J.E., Haffajee C.I., Alpert J.S., et al. Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med. 1977;196:1431–1436. doi: 10.1056/NEJM197706232962503. [DOI] [PubMed] [Google Scholar]
  • 179.Hampton A.O., Castleman B. Correlation of postmortem chest teleroentgenograms with autopsy findings. Am J Roentgenol Radium Ther. 1940;43:305–326. [Google Scholar]
  • 180.Libby L.S., King T.E., Laforce F.M., et al. Pulmonary cavitation following pulmonary infarction. Medicine. 1985;64:342–348. doi: 10.1097/00005792-198509000-00006. [DOI] [PubMed] [Google Scholar]
  • 181.Jaffe R.B., Koschmann E.B. Septic pulmonary emboli. Radiology. 1970;96:527–532. doi: 10.1148/96.3.527. [DOI] [PubMed] [Google Scholar]
  • 182.Huang R.M., Naidich D.P., Lubat E., et al. Septic pulmonary emboli: CT-radiographic correlation. AJR. 1989;153:41–45. doi: 10.2214/ajr.153.1.41. [DOI] [PubMed] [Google Scholar]
  • 183.Redline S., Tomashefski J.F., Altose M.D. Cavitating lung infarction after bland pulmonary thromboembolism in patients with the adult respiratory distress syndrome. Thorax. 1985;40:915–919. doi: 10.1136/thx.40.12.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 184.Miller J.I., Harrison E.G., Bernatz P.E. Surgically treated unsuspected pulmonary infarction. Ann Thorac Surg. 1972;14:181–188. doi: 10.1016/S0003-4975(10)65216-2. [DOI] [PubMed] [Google Scholar]
  • 185.Houk V.N., Hufnagel C.A., McClenathan J.E., et al. Chronic thrombotic obstruction of major pulmonary arteries. Report of a case successfully treated by thromboendarterectomy, and a review of the literature. Am J Med. 1963;35:269–282. doi: 10.1016/0002-9343(63)90218-3. [DOI] [PubMed] [Google Scholar]
  • 186.Fedullo P.D., Auger W.R., Kerr K.M., et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345:1465–1472. doi: 10.1056/NEJMra010902. [DOI] [PubMed] [Google Scholar]
  • 187.Rich S., Levitsky S., Brundage B.H. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann Intern Med. 1988;108:425–434. doi: 10.7326/0003-4819-108-3-425. [DOI] [PubMed] [Google Scholar]
  • 188.Williamson T.L., Kim N.H., Rubin L.J. Chronic thromboembolic pulmonary hypertension. Prog Cardiovasc Dis. 2002;45:203–212. doi: 10.1053/pcad.2002.130159. [DOI] [PubMed] [Google Scholar]
  • 189.Moser K.M., Houk V.N., Jones R.C., et al. Chronic, massive thrombotic obstruction of the pulmonary arteries. Analysis of four operated cases. Circulation. 1965;32:377–385. doi: 10.1161/01.CIR.32.3.377. [DOI] [PubMed] [Google Scholar]
  • 190.Pengo V., Lensing A.W.A., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:225–228. doi: 10.1056/NEJMoa032274. [DOI] [PubMed] [Google Scholar]
  • 191.Ball K.P., Goodwin J.F., Harrison C.V. Massive thrombotic occlusion of the large pulmonary arteries. Circulation. 1956;14:766–783. doi: 10.1161/01.CIR.14.5.766. [DOI] [PubMed] [Google Scholar]
  • 192.Scully R.E., Mark E.J., McNeely B.U. Case records of the Massachusetts General Hospital. Case 38-1981. N Engl J Med. 1981;305:685–693. doi: 10.1056/NEJM198109173051208. [DOI] [PubMed] [Google Scholar]
  • 193.Moser K.M., Daily P.O., Peterson K., et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Ann Intern Med. 1987;107:560–564. doi: 10.7326/0003-4819-107-4-560. [DOI] [PubMed] [Google Scholar]
  • 194.Archibald C.J., Auger W.R., Fedullo P.F., et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523–528. doi: 10.1164/ajrccm.160.2.9808109. [DOI] [PubMed] [Google Scholar]
  • 195.Lang I.M. Chronic thromboembolic pulmonary hypertension—not so rare after all. N Engl J Med. 2004;350:2236–2237. doi: 10.1056/NEJMp048088. [DOI] [PubMed] [Google Scholar]
  • 196.Hirsch A.M., Moser K.M., Auger W.R., et al. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Am J Respir Crit Care Med. 1996;154:491–196. doi: 10.1164/ajrccm.154.2.8756827. [DOI] [PubMed] [Google Scholar]
  • 197.Blauwet L.A., Edwards W.D., Tazelaar H.D., et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol. 2003;34:1290–1298. doi: 10.1016/j.humpath.2003.07.003. [DOI] [PubMed] [Google Scholar]
  • 198.Berry D.F., Buccigrossi D., Peabody J., et al. Pulmonary vascular occlusion and fibrosing mediastinitis. Chest. 1986;89:296–301. doi: 10.1378/chest.89.2.296. [DOI] [PubMed] [Google Scholar]
  • 199.Hicks GL Jr. Fibrosing mediastinitis. Causing pulmonary artery and vein obstruction with hemoptysis. NY State J Med 1983;242–244. [PubMed]
  • 200.Moser K.M., Bloor C.M. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685–692. doi: 10.1378/chest.103.3.685. [DOI] [PubMed] [Google Scholar]
  • 201.Owen W.R., Thomas W.A., Castleman B., et al. Unrecognized emboli to the lungs with subsequent cor pulmonale. N Engl J Med. 1953;249:919–926. doi: 10.1056/NEJM195312032492302. [DOI] [PubMed] [Google Scholar]
  • 202.Carson J.L., Kelley M.A., Duff A., et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240–1245. doi: 10.1056/NEJM199205073261902. [DOI] [PubMed] [Google Scholar]
  • 203.Paraskos J.A., Adelstein S.J., Smith R.E., et al. Late prognosis of acute pulmonary embolism. N Engl J Med. 1973;289:55–58. doi: 10.1056/NEJM197307122890201. [DOI] [PubMed] [Google Scholar]
  • 204.Piatt O.S. The acute chest syndrome of sickle cell disease. N Engl J Med. 2000;342:1904–1906. doi: 10.1056/NEJM200006223422510. [DOI] [PubMed] [Google Scholar]
  • 205.Minter K.R., Gladwin M.T. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med. 2001;164:2016–2019. doi: 10.1164/ajrccm.164.11.2104101. [DOI] [PubMed] [Google Scholar]
  • 206.Weil J.V., Castro O., Malik A.B., et al. Pathogenesis of lung disease in sickle hemoglobinopathies. Am Rev Respir Dis. 1993;148:249–256. doi: 10.1164/ajrccm/148.1.249. [DOI] [PubMed] [Google Scholar]
  • 207.Bromberg P.A. Pulmonary aspects of sickle cell disease. Arch Intern Med. 1974;133:652–657. doi: 10.1001/archinte.1974.00320160146013. [DOI] [PubMed] [Google Scholar]
  • 208.Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine. 1971;50:97–112. doi: 10.1097/00005792-197103000-00002. [DOI] [PubMed] [Google Scholar]
  • 209.Barrett-Connor E. Pneumonia and pulmonary infarction in sickle cell anemia. JAMA. 1973;224:997–1000. doi: 10.1001/jama.1973.03220210021004. [DOI] [PubMed] [Google Scholar]
  • 210.Sears D.A. The morbidity of sickle cell trait. A review of the literature. Am J Med. 1978;64:1021–1036. doi: 10.1016/0002-9343(78)90458-8. [DOI] [PubMed] [Google Scholar]
  • 211.Israel R.H., Salipante J.S. Pulmonary infarction in sickle cell trait. Am J Med. 1979;66:867–869. doi: 10.1016/0002-9343(79)91139-2. [DOI] [PubMed] [Google Scholar]
  • 212.Davies S.C., Winn A.A., Luce P.J., et al. Acute chest syndrome in sickle-cell disease. Lancet. 1984;1:36–38. doi: 10.1016/S0140-6736(84)90193-4. [DOI] [PubMed] [Google Scholar]
  • 213.Vichinsky E.P., Neumayr L.D., Earles A.N., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med. 2000;342:1855–1865. doi: 10.1056/NEJM200006223422502. [DOI] [PubMed] [Google Scholar]
  • 214.Shelley W.M., Curtis E.M. Bone marrow and fat embolism in sickle cell anemia and sickle cell-hemoglobin C disease. Bull Johns Hopkins Hosp. 1958;103:8–26. [PubMed] [Google Scholar]
  • 215.Haynes J., Jr, Allison R.C. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med. 1986;80:833–840. doi: 10.1016/0002-9343(86)90624-8. [DOI] [PubMed] [Google Scholar]
  • 216.Powars D., Weidman J.A., Odom-Maryon T., et al. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine. 1983;67:66–76. [PubMed] [Google Scholar]
  • 217.Collins F.S., Orringer E.P. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med. 1982;73:814–821. doi: 10.1016/0002-9343(82)90763-X. [DOI] [PubMed] [Google Scholar]
  • 218.Gladwin M.T., Sachdev V., Jison M.L., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886–895. doi: 10.1056/NEJMoa035477. [DOI] [PubMed] [Google Scholar]
  • 219.CPC Conference Sudden death in a young woman with sickle cell anemia. Am J Med. 1992;92:556–560. doi: 10.1016/0002-9343(92)90754-Y. [DOI] [PubMed] [Google Scholar]
  • 220.Haupt H.M., Moore G.W., Bauer T.W., et al. The lung in sickle cell disease. Chest. 1982;81:332–337. doi: 10.1378/chest.81.3.332. [DOI] [PubMed] [Google Scholar]
  • 221.Adedeji M.O., Cespedes J., Allen K. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med. 2001;125:1436–1442. doi: 10.5858/2001-125-1436-PTAIPW. [DOI] [PubMed] [Google Scholar]
  • 222.Oppenheimer E.H., Esterly J.R. Pulmonary changes in sickle cell disease. Am Rev Respir Dis. 1971;103:858–859. doi: 10.1164/arrd.1971.103.6.858. [DOI] [PubMed] [Google Scholar]
  • 223.Yung G.L., Channick R.N., Fedullo P.F., et al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med. 1998;157:1690–1693. doi: 10.1164/ajrccm.157.5.9710032. [DOI] [PubMed] [Google Scholar]
  • 224.Haque A.K., Gokhale S., Rampy B.A., et al. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol. 2002;33:1037–1051. doi: 10.1053/hupa.2002.128059. [DOI] [PubMed] [Google Scholar]
  • 225.Scully R.E., Mark E.J., McNeely B.U., et al. Case records of the Massachusetts General Hospital. Case 52-1983. N Engl J Med. 1983;309:1627–1636. doi: 10.1056/NEJM198312293092607. [DOI] [PubMed] [Google Scholar]
  • 226.Yater W.M., Hansmann G.H. Sickle-cell anemia: a new cause of cor pulmonale. Report of two cases with numerous disseminated occlusions of the small pulmonary arteries. Am J Med Sci. 1936;191:474–484. [Google Scholar]
  • 227.Scully R.E., Mark E.J., McNeely W.F., et al. Case records of the Massachusetts General Hospital. Case 34-1997. N Engl J Med. 1997;337:1293–1301. doi: 10.1056/NEJM199710303371808. [DOI] [PubMed] [Google Scholar]
  • 228.Eckardt P., Raez L.E., Restrepo A., et al. Pulmonary bone marrow embolism in sickle cell disease. South Med J. 1999;92:245–247. doi: 10.1097/00007611-199902000-00018. [DOI] [PubMed] [Google Scholar]
  • 229.Godeau B., Schaeffer A., Bachir D., et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med. 1996;153:1691–1696. doi: 10.1164/ajrccm.153.5.8630622. [DOI] [PubMed] [Google Scholar]
  • 230.Heath D., Thompson I.M. Bronchopulmonary anastomoses in sickle-cell anaemia. Thorax. 1969;24:232–238. doi: 10.1136/thx.24.2.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 231.Hebbel R.P. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N Engl J Med. 2000;342:1910–1911. doi: 10.1056/NEJM200006223422512. [DOI] [PubMed] [Google Scholar]
  • 232.Hammerman S.I., Kourembanas S., Conca T.J. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 1997;156:280–285. doi: 10.1164/ajrccm.156.1.9611085. [DOI] [PubMed] [Google Scholar]
  • 233.Rossi S.E., Goodman P.C., Franquet T. Nonthrombotic pulmonary emboli. AJR. 2000;174:1499–1508. doi: 10.2214/ajr.174.6.1741499. [DOI] [PubMed] [Google Scholar]
  • 234.Havig O., Gruner O.P.N. Pulmonary bone marrow embolism. Acta Path Microbiol Scand. 1973;81:276–280. [PubMed] [Google Scholar]
  • 235.Rappaport H., Horrell R.M. Bone marrow embolism. Am J Pathol. 1951;27:407–435. [PMC free article] [PubMed] [Google Scholar]
  • 236.Pyun K.S., Katzenstein R.E. Widespread bone marrow embolism with myocardial involvement. Arch Pathol. 1979;89:378–381. [PubMed] [Google Scholar]
  • 237.McCarty P.J., Shmookler B.M., Pierce L.E. Fatal bone marrow pulmonary emboli in multiple myeloma. Ann Intern Med. 1977;86:317–318. doi: 10.7326/0003-4819-86-3-317. [DOI] [PubMed] [Google Scholar]
  • 238.Yanoff M. Incidence of bone marrow embolism due to closed-chest cardiac massage. N Engl J Med. 1963;269:837–839. doi: 10.1056/NEJM196310172691604. [DOI] [PubMed] [Google Scholar]
  • 239.Garvey J.W., Zak F.G. Pulmonary bone marrow emboli in patients receiving external cardiac massage. JAMA. 1964;187:59–60. doi: 10.1001/jama.1964.03060140065023. [DOI] [PubMed] [Google Scholar]
  • 240.Abrahams C., Catchatourian R. Bone fragment emboli in the lungs of patients undergoing bone marrow transplantation. Am J Clin Pathol. 1983;79:360–363. doi: 10.1093/ajcp/79.3.360. [DOI] [PubMed] [Google Scholar]
  • 241.Sharnoff J.G., Kim E.S. Evaluation of pulmonary megakaryocytes. Arch Pathol. 1958;66:176–182. [PubMed] [Google Scholar]
  • 242.Wells S., Sissons M., Hasleton P.S. Quantitation of pulmonary megakaryocytes and fibrin thrombi from patients dying from burns. Histopathology. 1984;8:517–527. doi: 10.1111/j.1365-2559.1984.tb02361.x. [DOI] [PubMed] [Google Scholar]
  • 243.Straus R. Pulmonary emboli caused by liver tissue. Arch Pathol. 1942;33:69–71. [Google Scholar]
  • 244.Lie J.T. Myocardium as emboli in the systemic and pulmonary circulation. Arch Pathol Lab Med. 1997;111:261–264. [PubMed] [Google Scholar]
  • 245.Tackett L.B. Brain tissue pulmonary emboli. Arch Pathol. 1964;78:292–294. [PubMed] [Google Scholar]
  • 246.McMillan J.B. Emboli of cerebral tissue in the lungs following severe head injury. Am J Pathol. 1956;32:405–415. [PMC free article] [PubMed] [Google Scholar]
  • 247.Levine S.B. Embolism of cerebral tissue to lungs. Arch Pathol Lab Med. 1973;96:183–185. [PubMed] [Google Scholar]
  • 248.Oppenheimer E.H. Massive pulmonary embolization by cerebral cortical tissue. Bull Johns Hopkins Hosp. 1954;94:86–93. [PubMed] [Google Scholar]
  • 249.Andrew J.H. Pulmonary skin embolism: a case report. Pathology. 1976;8:185–187. doi: 10.3109/00313027609058996. [DOI] [PubMed] [Google Scholar]
  • 250.Bassiri A.G., Haghighi B., Doyle R.L., et al. Pulmonary tumor embolism. Am J Respir Crit Care Med. 1997;155:2089–2095. doi: 10.1164/ajrccm.155.6.9196119. [DOI] [PubMed] [Google Scholar]
  • 251.Soares F.A., Landell G.A.M., de Oliveira J.A.M. Pulmonary tumor embolism to alveolar septal capillaries. Arch Pathol Lab Med. 1991;115:127–130. [PubMed] [Google Scholar]
  • 252.Kane R.D., Hawkins H.K., Miller J.A. Microscopic pulmonary tumor emboli associated with dyspnea. Cancer. 1975;36:1473–1482. doi: 10.1002/1097-0142(197510)36:4<1473::AID-CNCR2820360440>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  • 253.von Herbay A., Hies A., Waldherr R., et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66:587–592. doi: 10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  • 254.Saphir O. The fate of carcinoma emboli in the lung. Am J Pathol. 1946;23:245–253. [PMC free article] [PubMed] [Google Scholar]
  • 255.Iwasaki T. Histological and experimental observations on the destruction of tumour cells in the blood vessels. J Pathol. 1915;20:85–105. doi: 10.1002/path.1700200109. [DOI] [Google Scholar]
  • 256.Harris N.L., McNeely W.F., Shepard J.A.O., et al. Case records of the Massachusetts General Hospital. Case 13-2002. N Engl J Med. 2002;346:1309–1318. doi: 10.1056/NEJMcpc010052. [DOI] [PubMed] [Google Scholar]
  • 257.Yao D.X., Flieder D.B., Hoda S.A. Pulmonary tumor thrombotic microangiopathy. Arch Pathol Lab Med. 2001;125:304–305. doi: 10.5858/2001-125-0304-PTTM. [DOI] [PubMed] [Google Scholar]
  • 258.Schriner R.W., Ryu J.H., Edwards W.D. Microscopic pulmonary tumor embolism causing subacute cor pulmonale: a difficult antemortem diagnosis. Mayo Clin Proc. 1991;66:143–148. doi: 10.1016/S0025-6196(12)60485-6. [DOI] [PubMed] [Google Scholar]
  • 259.Brill I.C., Robertson T.D. Subacute cor pulmonale. Arch Intern Med. 1937;60:1043–1057. doi: 10.1001/archinte.1937.00180060096010. [DOI] [Google Scholar]
  • 260.Winterbauer R.H., Elfenbein I.B., Ball W.C. Incidence and clinical significance of tumor embolization to the lungs. Am J Med. 1968;45:271–290. doi: 10.1016/0002-9343(68)90044-2. [DOI] [PubMed] [Google Scholar]
  • 261.Gonzalez A., Altieri P.I., Marquez E., et al. Massive pulmonary embolism associated with a right ventricular myxoma. Am J Med. 1980;69:795–798. doi: 10.1016/0002-9343(80)90455-6. [DOI] [PubMed] [Google Scholar]
  • 262.Scully R.E. Fat embolism in Korean battle casualties: its incidence, clinical significance and pathologic aspects. Am J Pathol. 1956;32:379–404. [PMC free article] [PubMed] [Google Scholar]
  • 263.Sevitt S. The significance and classification of fat embolism. Lancet. 1960;2:825–828. doi: 10.1016/S0140-6736(60)91901-2. [DOI] [PubMed] [Google Scholar]
  • 264.Chan K.M., Tham K.T., Chiu H.S., et al. Posttraumatic fat embolism. Its clinical and subclinical presentations. J Trauma. 1984;24:45–49. doi: 10.1097/00005373-198401000-00007. [DOI] [PubMed] [Google Scholar]
  • 265.Liban E., Raz S. A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol. 1969;51:477–486. doi: 10.1093/ajcp/51.4.477. [DOI] [PubMed] [Google Scholar]
  • 266.Attwood H.D. Amniotic fluid embolism. Pathol Annu. 1972;7:145–172. [PubMed] [Google Scholar]
  • 267.Attwood H.D., Park W.W. Embolism to the lungs by trophoblast. J Obstet Gynecol. 1961;68:611–617. doi: 10.1111/j.1471-0528.1961.tb02778.x. [DOI] [PubMed] [Google Scholar]
  • 268.Roffman B.Y., Simons M. Syncytial trophoblastic embolism associated with placenta increta and preeclampsia. Am J Obstet Gynecol. 1969;104:1218–1219. doi: 10.1016/s0002-9378(16)34299-5. [DOI] [PubMed] [Google Scholar]
  • 269.Trotter R.F., Tieche H.L. Maternal death due to pulmonary embolism of trophoblastic cells. Am J Obstet Gynecol. 1956;71:1114–1118. doi: 10.1016/0002-9378(56)90737-2. [DOI] [PubMed] [Google Scholar]
  • 270.Arnold H.A., Bainborough A.R. Subacute cor pulmonale following trophoblastic pulmonary emboli. Can Med Assoc J. 1957;76:478–482. [PMC free article] [PubMed] [Google Scholar]
  • 271.Delmis J., Preifer D., Ivanisevic M., et al. Sudden death from trophoblastic embolism in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2000;92:225–227. doi: 10.1016/S0301-2115(99)00281-X. [DOI] [PubMed] [Google Scholar]
  • 272.Park W.W. The occurrence of decidual tissue within the lung: report of a case. J Pathol Bacteriol. 1954;67:563–570. doi: 10.1002/path.1700670229. [DOI] [PubMed] [Google Scholar]
  • 273.Schneider C.L. Rupture of the basal (decidual) plate in abruptio placentae: a pathway of autoextraction from the decidua into the maternal circulation. Am J Obstet Gynecol. 1952;63:1078–1090. doi: 10.1016/0002-9378(52)90548-6. [DOI] [PubMed] [Google Scholar]
  • 274.Flieder D.B., Moran C.A., Travis W.D., et al. Pleuropulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis on diagnostic pitfalls. Hum Pathol. 1998;29:1495–1503. doi: 10.1016/S0046-8177(98)90021-1. [DOI] [PubMed] [Google Scholar]
  • 275.Dimmick J.E., Bove K.E., McAdams A.J., et al. Fiber embolization: a hazard of cardiac surgery and catheterization. N Engl J Med. 1975;292:685–687. doi: 10.1056/NEJM197503272921308. [DOI] [PubMed] [Google Scholar]
  • 276.Tang T.T., Chamers C.G., Gallen W.J., et al. Pulmonary fiber embolism and granuloma. JAMA. 1978;239:948–950. doi: 10.1001/jama.1978.03280370044022. [DOI] [PubMed] [Google Scholar]
  • 277.Glassroth J., Adams G.D., Schnoll S. The impact of substance abuse on the respiratory system. Chest. 1987;91:596–602. doi: 10.1378/chest.91.4.596. [DOI] [PubMed] [Google Scholar]
  • 278.Tomashefski J.F., Jr, Hirsch C.S. The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol. 1980;11:133–145. doi: 10.1016/S0046-8177(80)80130-4. [DOI] [PubMed] [Google Scholar]
  • 279.Tomashefski J.F., Jr, Felo J.A. The pulmonary pathology of illicit drug and substance abuse. Current Diagn Pathol. 2004;10:413–426. doi: 10.1016/j.cdip.2004.04.009. [DOI] [Google Scholar]
  • 280.Pomerance H.H., Rader R.E. Crystal formation: a new complication of total parenteral nutrition. Pediatr. 1973;52:864–866. [PubMed] [Google Scholar]
  • 281.Knowles J.B., Cussons G., Smith M., et al. Pulmonary deposition of calcium phosphate crystals as a complication of home total parenteral nutrition. J Parent Enteral Nutr. 1989;13:209–213. doi: 10.1177/0148607189013002209. [DOI] [PubMed] [Google Scholar]
  • 282.Hill S.E., Heldman L.S., Goo E.D.G., et al. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution. J Parent Enteral Nutr. 1995;20:81–87. doi: 10.1177/014860719602000181. [DOI] [PubMed] [Google Scholar]
  • 283.Dahms B.B., Halpin T.C., Jr. Pulmonary arterial lipid deposits in newborn infants receiving intravenous lipid infusion. J Pediatr. 1980;97:800–805. doi: 10.1016/S0022-3476(80)80274-5. [DOI] [PubMed] [Google Scholar]
  • 284.Redline R.W., Dahms B.B. Malassezia pulmonary vasculitis in an infant on long-term Intralipid therapy. N Engl J Med. 1981;305:1395–1398. doi: 10.1056/NEJM198112033052307. [DOI] [PubMed] [Google Scholar]
  • 285.Sabatine M.S., Oelbert D.A., Mark E.J., et al. Pulmonary cholesterol crystal embolization. Chest. 1997;112:1687–1692. doi: 10.1378/chest.112.6.1687. [DOI] [PubMed] [Google Scholar]
  • 286.Scully R.E., Mark E.J., McNeely W.F., et al. Case records of the Massachusetts General Hospital. Case 11-1996. N Engl J Med. 1996;334:973–979. doi: 10.1056/NEJM199604113341508. [DOI] [PubMed] [Google Scholar]
  • 287.Joels C.S., Sing R.F., Heniford B.T. Complications of inferior vena cava filters. Am Surg. 2003;69:654–659. [PubMed] [Google Scholar]
  • 288.Weingarten J., Kauffman S.L. Teflon embolization of pulmonary arteries. Ann Thorac Surg. 1977;23:371–373. doi: 10.1016/S0003-4975(10)64145-8. [DOI] [PubMed] [Google Scholar]
  • 289.Chung K.Y., Kim S.H., Hwon I.H., et al. Clinicopathologic review of pulmonary silicone embolism with special emphasis on the resultant histologic diversity in the lung—a review of five cases. Yonsei Med J. 2002;43:152–159. doi: 10.3349/ymj.2002.43.2.152. [DOI] [PubMed] [Google Scholar]
  • 290.Chen Y.M., Lu C.C., Perng R.P. Silicone fluid-induced pulmonary embolism. Am Rev Respir Dis. 1993;147:1299–1302. doi: 10.1164/ajrccm/147.5.1299. [DOI] [PubMed] [Google Scholar]
  • 291.Chastre J., Brun P., Soler P., et al. Acute and latent pneumonitis after subcutaneous injections of silicone in transsexual men. Am Rev Respir Dis. 1987;135:236–240. doi: 10.1164/arrd.1987.135.1.236. [DOI] [PubMed] [Google Scholar]
  • 292.Chastre J., Basset F., Viau F., et al. Acute pneumonitis after subcutaneous injections of silicone in transsexual men. N Engl J Med. 1983;308:764–767. doi: 10.1056/NEJM198303313081307. [DOI] [PubMed] [Google Scholar]
  • 293.Oliver R.M., Thomas M.R., Cornsby A.J., et al. Mercury pulmonary emboli following intravenous self-injection. Br J Dis Chest. 1987;81:76–79. doi: 10.1016/0007-0971(87)90111-2. [DOI] [PubMed] [Google Scholar]
  • 294.Gutierrez F., Leon L. Elemental mercury embolism to the lung. Images in Clinical Medicine. N Engl J Med. 2000;342:1791. doi: 10.1056/NEJM200006153422405. [DOI] [PubMed] [Google Scholar]
  • 295.Truemner K.M., White S. Fatal embolization of pulmonary capillaries. Report of case associated with routine barium enema. JAMA. 1960;173:119–1092. doi: 10.1001/jama.1960.03020280029006. [DOI] [PubMed] [Google Scholar]
  • 296.Balogh K. Pulmonary bile emboli. Sequelae of iatrogenic trauma. Arch Pathol Lab Med. 1984;108:814–816. [PubMed] [Google Scholar]
  • 297.Smith R.R.L., Hutchins G.M. Pulmonary fecal embolization complicating the Budd-Chiari syndrome. N Engl J Med. 1978;298:1069–1070. doi: 10.1056/NEJM197805112981908. [DOI] [PubMed] [Google Scholar]
  • 298.Wagenvoort C.A., Mooi W.J. Vascular diseases. In: Dail D.H., Hammar S.P., editors. Pulmonary pathology. 2nd ed. New York: Springer-Verlag; 1993. pp. 985–1026. [Google Scholar]
  • 299.Tomashefski J.F., Cohen A.M., Doershuk C.F. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Hum Pathol. 1988;19:555–561. doi: 10.1016/S0046-8177(88)80204-1. [DOI] [PubMed] [Google Scholar]
  • 300.Ro J.Y., Tsakalakis P.J., White V.A. Pulmonary dirofilariasis: the great imitator of primary or metastatic lung tumor. A clinicopathologic analysis of seven cases and a review of the literature. Hum Pathol. 1989;20:69–80. doi: 10.1016/0046-8177(89)90205-0. [DOI] [PubMed] [Google Scholar]
  • 301.Flieder D.B., Moran C.A. Pulmonary dirofilariasis: a clinicopathologic study of 41 lesions in 39 patients. Hum Pathol. 1999;30:251–256. doi: 10.1016/S0046-8177(99)90001-1. [DOI] [PubMed] [Google Scholar]
  • 302.Gutierrez Y. Diagnostic pathology of parasitic infections with clinical correlations. 2nd ed. New York: Oxford University Press; 2000. pp. 545–576. [Google Scholar]
  • 303.Matthay M.A. Pathophysiology of pulmonary edema. Clin Chest Med. 1985;6:301–314. [PubMed] [Google Scholar]
  • 304.Pietra G.G. Biology of disease. New insights into mechanisms of pulmonary edema. Lab Invest. 1984;51:489–494. [PubMed] [Google Scholar]
  • 305.Staub N.C. The pathogenesis of pulmonary edema. Prog Cardiovasc Dis. 1980;23:53–80. doi: 10.1016/0033-0620(80)90005-5. [DOI] [PubMed] [Google Scholar]
  • 306.Staub N.C. The pathophysiology of pulmonary edema. Hum Pathol. 1970;1:420–432. doi: 10.1016/S0046-8177(70)80075-2. [DOI] [PubMed] [Google Scholar]
  • 307.Wagenvoort C.A., Wagenvoort N. Pulmonary venous hypertension. In: Wagenvoort C.A., Wagenvoort N., editors. Pathology of pulmonary hypertension. New York: John Wiley & Sons; 1977. pp. 177–216. [Google Scholar]
  • 308.Heath D., Edwards J.E. Histological changes in the lung in diseases associated with pulmonary venous hypertension. Br J Dis Chest. 1959;53:8–18. doi: 10.1016/S0007-0971(59)80105-4. [DOI] [PubMed] [Google Scholar]
  • 309.Scully R.E., Mark E.J., McNeely W.F., et al. Case records of the Massachusetts General Hospital. Case 17-1995. N Engl J Med. 1995;332:1566–1572. doi: 10.1056/NEJM199506083322308. [DOI] [PubMed] [Google Scholar]
  • 310.Bindelglass I.L., Trubowitz S. Pulmonary vein obstruction: an uncommon sequel to chronic fibrous mediastinitis. Ann Intern Med. 1958;48:876–891. doi: 10.7326/0003-4819-48-4-876. [DOI] [PubMed] [Google Scholar]
  • 311.Edwards J.E., Burchell H.B. Multilobar pulmonary venous obstruction with pulmonary hypertension. “Protective” arterial lesions in the involved lobes. AMA Arch Intern Med. 1951;87:373–378. doi: 10.1001/archinte.1951.03810030045004. [DOI] [PubMed] [Google Scholar]
  • 312.Davis F.W., Andrus E.C. Mitral stenosis in facsimile. N Engl J Med. 1954;251:297–302. doi: 10.1056/NEJM195408192510803. [DOI] [PubMed] [Google Scholar]
  • 313.Botticelli J.T., Schlueter D.P., Lange R.L. Pulmonary venous and arterial hypertension due to chronic fibrous mediastinitis. Hemodynamics and pulmonary function. Circulation. 1966;33:862–871. doi: 10.1161/01.CIR.33.6.862. [DOI] [PubMed] [Google Scholar]
  • 314.Inkley S.R., Abbott G.R. Unilateral pulmonary arteriosclerosis. Unusual fibrous connective tissue growth associated: review of literature and discussion of possible physiological mechanisms involved in these changes. Arch Intern Med. 1961;108:147–159. doi: 10.1001/archinte.1961.03620120087012. [DOI] [Google Scholar]
  • 315.Goodale F., Jr, Sanchez G., Friedlich A.L. Correlation of pulmonary arteriolar resistance with pulmonary vascular changes in patients with mitral stenosis before and after valvulotomy. N Engl J Med. 1955;252:979–983. doi: 10.1056/NEJM195506092522303. [DOI] [PubMed] [Google Scholar]
  • 316.Heath D., Whitaker W. The pulmonary vessels in mitral stenosis. J Pathol Bacteriol. 1955;70:2391–298. doi: 10.1002/path.1700700204. [DOI] [PubMed] [Google Scholar]
  • 317.Ward C., Hancock B.W. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J. 1975;37:74–78. doi: 10.1136/hrt.37.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 318.Bates D.V., Macklem P.T., Christie R.V. Respiratory function in disease. Philadelphia: WB Saunders; 1971. pp. 330–333. [Google Scholar]
  • 319.Cortese D.A. Pulmonary function in mitral stenosis. Mayo Clin Proc. 1978;53:321–326. [PubMed] [Google Scholar]
  • 320.Moolten S.E. Pulmonary fibrosis in rheumatic heart disease. Am J Med. 1962;33:421–441. doi: 10.1016/0002-9343(62)90238-3. [DOI] [PubMed] [Google Scholar]
  • 321.Parker F., Jr, Weiss S. The nature and significance of the structural changes in the lungs in mitral stenosis. Am J Pathol. 1936;12:573–598. [PMC free article] [PubMed] [Google Scholar]
  • 322.Jing X., Yokoi T., Nakamura Y., et al. Pulmonary capillary hemangiomatosis: a unique feature of congestive vasculopathy associated with hypertrophic cardiomyopathy. Arch Pathol Lab Med. 1998;122:94–96. [PubMed] [Google Scholar]
  • 323.Taylor H.E., Strong G.F. Pulmonary hemosiderosis in mitral stenosis. Ann Intern Med. 1955;42:26–35. doi: 10.7326/0003-4819-42-1-26. [DOI] [PubMed] [Google Scholar]
  • 324.Heath D., Whitaker W. The relation of pulmonary haemosiderosis to hypertension in the pulmonary arteries and veins in mitral stenosis and congenital heart disease. J Pathol Bacteriol. 1956;122:531–541. doi: 10.1002/path.1700720218. [DOI] [Google Scholar]
  • 325.Weir J.A., Piccoli A.J., Greene D.G., et al. Mitral stenosis with exertional cyanosis and pulmonary hemosiderosis. Circulation. 1952;6:868–873. doi: 10.1161/01.CIR.6.6.868. [DOI] [PubMed] [Google Scholar]
  • 326.Walton K.W., Heath D. Iron incrustation of the pulmonary vessels in patent ductus arteriosus with congenital mitral disease. Br Heart J. 1960;22:440–444. doi: 10.1136/hrt.22.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 327.Pai U., McMahon J., Tomashefski J.F., Jr Mineralizing pulmonary elastosis in chronic cardiac failure. Am J Clin Pathol. 1994;101:22–28. doi: 10.1093/ajcp/101.1.22. [DOI] [PubMed] [Google Scholar]
  • 328.Jordan S.C., Hicken P., Watson D.A., et al. Pathology of the lungs in mitral stenosis in relation to respiratory function and pulmonary haemodynamics. Br Heart J. 1966;28:101–106. doi: 10.1136/hrt.28.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 329.Thomas W.A., Lee K.T., Rabin E.R., et al. Mitral stenosis and pulmonary arteriosclerosis. Correlation of pulmonary arteriosclerosis, right ventricular hypertrophy, and thromboembolism in autopsied patients who died with mitral stenosis. AMA Arch Pathol. 1956;62:257–261. [PubMed] [Google Scholar]
  • 330.Heath D., Hicken P. The relation between left atrial hypertension and lymphatic distension in lung biopsies. Thorax. 1960;15:54–58. doi: 10.1136/thx.15.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 331.Heath D., Segel N., Bishop J. Pulmonary veno-occlusive disease. Circulation. 1966;34:242–248. doi: 10.1161/01.CIR.34.2.242. [DOI] [PubMed] [Google Scholar]
  • 332.Wagenvoort C.A. Pulmonary veno-occlusive disease. Entity or syndrome? Chest. 1976;69:82–86. doi: 10.1378/chest.69.1.82. [DOI] [PubMed] [Google Scholar]
  • 333.Mandel J., Mark E.J., Hales C. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964–1973. doi: 10.1164/ajrccm.162.5.9912045. [DOI] [PubMed] [Google Scholar]
  • 334.Hasleton P.S., Ironside J.W., Whittaker J.S., et al. Pulmonary veno-occlusive disease. A report of four cases. Histopathology. 1986;10:933–934. doi: 10.1111/j.1365-2559.1986.tb02591.x. [DOI] [PubMed] [Google Scholar]
  • 335.Chawla S.K., Kittle C.F., Faber L.P., et al. Pulmonary veno-occlusive disease. Ann Thorac Surg. 1976;22:249–253. doi: 10.1016/S0003-4975(10)64911-9. [DOI] [PubMed] [Google Scholar]
  • 336.Dail D.H. Uncommon tumors. In: Dail D.H., Hammar S.P., editors. Pulmonary pathology. 2nd ed. New York: Springer-Verlag; 1993. pp. 1424–1430. [Google Scholar]
  • 337.Bolster M.A., Hogan J., Bredin C.P. Pulmonary veno-occlusive disease presenting as sudden death. Med Sci Law. 1990;30:26–28. doi: 10.1177/002580249003000106. [DOI] [PubMed] [Google Scholar]
  • 338.Cagle P., Langston C. Pulmonary veno-occlusive disease as a cause of sudden infant death. Arch Pathol Lab Med. 1984;108:338–340. [PubMed] [Google Scholar]
  • 339.Doll D.C., Yarbro J.W. Vascular toxicity associated with chemotherapy and hormonotherapy. Curr Opin Oncol. 1994;6:345–350. doi: 10.1097/00001622-199407000-00004. [DOI] [PubMed] [Google Scholar]
  • 340.Salzman D., Adkins D.R., Craig F., et al. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review. Bone Marrow Transplant. 1996;18:755–760. [PubMed] [Google Scholar]
  • 341.Tsuo E., Waldhorn R.E., Kerwin D.M., et al. Pulmonary veno-occlusive disease in pregnancy. Obstet Gynecol. 1984;64:281–284. [PubMed] [Google Scholar]
  • 342.Davies P., Reid L. Pulmonary veno-occlusive disease in siblings: case report and morphometric study. Hum Pathol. 1982;13:911–915. doi: 10.1016/S0046-8177(82)80051-8. [DOI] [PubMed] [Google Scholar]
  • 343.Wagenvoort C.A., Wagenvoort N., Takahashi T. Pulmonary veno-occlusive disease. Involvement of pulmonary arteries and review of the literature. Hum Pathol. 1985;16:1033–1041. doi: 10.1016/S0046-8177(85)80281-1. [DOI] [PubMed] [Google Scholar]
  • 344.Palmer S.M., Robinson L.J., Wang A., et al. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998;113:237–240. doi: 10.1378/chest.113.1.237. [DOI] [PubMed] [Google Scholar]
  • 345.Sanderson J.E., Spiro S.G., Hendry A.T., et al. A case of pulmonary veno-occlusive disease responding to treatment with azathioprine. Thorax. 1977;32:140–148. doi: 10.1136/thx.32.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 346.Shackelford G.D., Sacks E.J., Mullins J.D., et al. Pulmonary veno-occlusive disease: case report and review of the literature. Am J Roentgenol. 1977;128:643–648. doi: 10.2214/ajr.128.4.643. [DOI] [PubMed] [Google Scholar]
  • 347.Wagenvoort C.A., Beetstra A., Spijker J. Capillary haemangiomatosis of the lung. Histopathology. 1978;2:401–406. doi: 10.1111/j.1365-2559.1978.tb01734.x. [DOI] [PubMed] [Google Scholar]
  • 348.Faber C.N., Yousem S.A., Dauber J.H., et al. Pulmonary capillary hemangiomatosis: a report of three cases and a review of the literature. Am Rev Respir Dis. 1989;140:808–813. doi: 10.1164/ajrccm/140.3.808. [DOI] [PubMed] [Google Scholar]
  • 349.Tron V., Magee F., Wright J.L., et al. Pulmonary capillary hemangiomatosis. Hum Pathol. 1986;17:1144–1149. doi: 10.1016/S0046-8177(86)80420-8. [DOI] [PubMed] [Google Scholar]
  • 350.Oviedo A., Abramson L.P., Worthington R., et al. Congenital pulmonary capillary hemangiomatosis: report of two cases and review of the literature. Pediatr Pulmonol. 2003;36:253–256. doi: 10.1002/ppul.10245. [DOI] [PubMed] [Google Scholar]
  • 351.Langleben D., Heneghan J.M., Batten A.P., et al. Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension. Ann Intern Med. 1988;109:106–109. doi: 10.7326/0003-4819-109-2-106. [DOI] [PubMed] [Google Scholar]
  • 352.White C.W., Sondheimer H.M., Crouch E.C., et al. Treatment of pulmonary capillary hemangiomatosis with recombinant interferon alpha-2a. N Engl J Med. 1989;320:1197–1200. doi: 10.1056/NEJM198905043201807. [DOI] [PubMed] [Google Scholar]
  • 353.Havlik D.M., Massie L.W., Williams W.L., et al. Pulmonary capillary hemangiomatosis-like foci. An autopsy study of 8 cases. Am J Clin Pathol. 2000;113:655–662. doi: 10.1309/9R7N-19BP-P5QJ-U8E7. [DOI] [PubMed] [Google Scholar]
  • 354.Almagro P., Julia J., Sanjaume M., et al. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension. Medicine. 2002;81:417–424. doi: 10.1097/00005792-200211000-00002. [DOI] [PubMed] [Google Scholar]
  • 355.Umezu H., Naito M., Yagisawa K., et al. An autopsy case of pulmonary capillary hemangiomatosis without evidence of pulmonary hypertension. Virchows Arch. 2001;439:586–592. doi: 10.1007/s004280100465. [DOI] [PubMed] [Google Scholar]
  • 356.de Perrot M., Waddell T.K., Chamberlain D., et al. De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant. 2003;22:698–700. doi: 10.1016/S1053-2498(02)00810-0. [DOI] [PubMed] [Google Scholar]
  • 357.Fishman A.P. Hypoxia on the pulmonary circulation. How and where in acts. Circ Res. 1976;38:221–231. doi: 10.1161/01.RES.38.4.221. [DOI] [PubMed] [Google Scholar]
  • 358.Bergofsky E.H., Bass B.G., Ferretti R., et al. Pulmonary vasoconstriction in response to precapillary hypoxemia. J Clin Invest. 1963;42:1201–1215. doi: 10.1172/JCI104806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 359.Hasleton P.S., Heath D., Brewer D.B. Hypertensive pulmonary vascular disease in state of chronic hypoxia. J Pathol Bacteriol. 1968;95:431–440. doi: 10.1002/path.1700950213. [DOI] [PubMed] [Google Scholar]
  • 360.Saldana M.J., Arias-Stella J. Pulmonary hypertension and pathology at high altitudes. In: Saldana M.J., editor. Pathology of pulmonary disease. Philadelphia: Lippincott; 1994. pp. 247–259. [Google Scholar]
  • 361.Hurtado A. Chronic mountain sickness. JAMA. 1942;120:1278–1282. doi: 10.1001/jama.1942.02830510016004. [DOI] [Google Scholar]
  • 362.Gupta M.L., Rao K.S., Anand I.S., et al. Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted? Am Rev Respir Dis. 1992;145:1201–1204. doi: 10.1164/ajrccm/145.5.1201. [DOI] [PubMed] [Google Scholar]
  • 363.Monge C. High altitude disease. Arch Intern Med. 1937;59:32. doi: 10.1001/archinte.1937.00170170038002. [DOI] [Google Scholar]
  • 364.Millman R.P., Fishman A.R. Sleep apnea syndromes. In: Fishman A., editor. Pulmonary diseases and disorders. 2nd ed. New York: McGraw-Hill; 1998. pp. 1347–1359. [Google Scholar]
  • 365.Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–123. doi: 10.1056/NEJM199304293281704. [DOI] [PubMed] [Google Scholar]
  • 366.Phillipson E.A. Sleep apnea—a major public health problem. N Engl J Med. 1993;328:1271–1273. doi: 10.1056/NEJM199304293281712. [DOI] [PubMed] [Google Scholar]
  • 367.Shamsuzaman A.S.M., Gersh B.J., Somers V.K. Obstructive sleep apnea. Implications for cardiac and vascular disease. JAMA. 2003;14:1906–1914. doi: 10.1001/jama.290.14.1906. [DOI] [PubMed] [Google Scholar]
  • 368.Shepard J.W., Jr Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin Proc. 1990;65:1250–1259. doi: 10.1016/S0025-6196(12)62749-9. [DOI] [PubMed] [Google Scholar]
  • 369.Carroll D. A peculiar type of cardiopulmonary failure associated with obesity. Am J Med. 1956;21:819–824. doi: 10.1016/0002-9343(56)90095-X. [DOI] [PubMed] [Google Scholar]
  • 370.Counihan T.B. Heart failure due to extreme obesity. Br Heart J. 1956;18:425–426. doi: 10.1136/hrt.18.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 371.Estes E.H., Jr, Sieker H.O., Mcintosh H.D., et al. Reversible cardiopulmonary syndrome with extreme obesity. Circulation. 1957;26:179–187. doi: 10.1161/01.CIR.16.2.179. [DOI] [PubMed] [Google Scholar]
  • 372.Seide M.J. Heart failure due to extreme obesity. N Engl J Med. 1957;257:1227–1230. doi: 10.1056/NEJM195712192572507. [DOI] [PubMed] [Google Scholar]
  • 373.Burwell C.S., Robin, Whaley R.D., et al. Extreme obesity associated with alveolar hypoventilation—a Pickwickian syndrome. Am J Med. 1956;21:811–818. doi: 10.1016/0002-9343(56)90094-8. [DOI] [PubMed] [Google Scholar]
  • 374.James T.N., Frame B., Coates E.O. De subitaneis mortibus. III. Pickwickian syndrome. Circulation. 1973;68:1311–1320. doi: 10.1161/01.CIR.48.6.1311. [DOI] [PubMed] [Google Scholar]
  • 375.Garni A.S., Howard D.E., Olson E.J., et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352:1206–1212. doi: 10.1056/NEJMoa041832. [DOI] [PubMed] [Google Scholar]
  • 376.Sajkov D., Cowie R.J., Thornton A.T., et al. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994;149:416–422. doi: 10.1164/ajrccm.149.2.8306039. [DOI] [PubMed] [Google Scholar]
  • 377.Atwood C.W., Jr, McCrory D., Garcia J.G., et al. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:72S–77S. doi: 10.1378/chest.126.1_suppl.72S. [DOI] [PubMed] [Google Scholar]
  • 378.Sanner B.M., Doberauer C., Konermann M., et al. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997;157:2483–2487. doi: 10.1001/archinte.1997.00440420115011. [DOI] [PubMed] [Google Scholar]
  • 379.Bady E., Achkar A., Pascal S., et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934–939. doi: 10.1136/thorax.55.11.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 380.Guidry U.C., Mendes L.A., Evans J.C., et al. Echocardiographic features of the right heart in sleep-disordered breathing. Am J Respir Crit Care Med. 2001;164:933–938. doi: 10.1164/ajrccm.164.6.2001092. [DOI] [PubMed] [Google Scholar]
  • 381.Hanley T., Platts M.M., Clifton M., et al. Heart failure of the hunchback. Q J Med. 1958;27:155–171. [PubMed] [Google Scholar]
  • 382.Bates D.V., Macklem P.T., Christie R.V. Respiratory function in disease. Philadelphia: WB Saunders; 1971. pp. 245–248. [Google Scholar]
  • 383.Naeye R.L. Kyphoscoliosis and cor pulmonale. A study of the pulmonary vascular bed. Am J Pathol. 1961;38:561–573. [PMC free article] [PubMed] [Google Scholar]
  • 384.Jeffrey T.K., Morrell N.W. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Progr Cardiovas Dis. 2002;45:173–202. doi: 10.1053/pcad.2002.130041. [DOI] [PubMed] [Google Scholar]
  • 385.Meyrick B., Reid L. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab Invest. 1978;38:188–200. [PubMed] [Google Scholar]
  • 386.Hislop A., Reid L. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1976;57:542–554. [PMC free article] [PubMed] [Google Scholar]
  • 387.Hislop A., Reid L. Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension. Br J Exp Pathol. 1977;58:653–662. [PMC free article] [PubMed] [Google Scholar]
  • 388.Howell K., Ooi H., Preston R., et al. Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia. Exp Physiol. 2004;89:66–72. doi: 10.1113/expphysiol.2003.026765. [DOI] [PubMed] [Google Scholar]
  • 389.Palmer L.A., Semenza G.L., Stoler M.H., et al. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol. 1998;274:LK212–L219. doi: 10.1152/ajplung.1998.274.2.L212. [DOI] [PubMed] [Google Scholar]
  • 390.Yu A.Y., Frid M.H., Shimoda L.A., et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol. 1998;275:L818–L826. doi: 10.1152/ajplung.1998.275.4.L818. [DOI] [PubMed] [Google Scholar]
  • 391.Saldana M., Arias-Stella J. Studies on the structure of the pulmonary trunk II. The evolution of the elastic configuration of the pulmonary trunk in people native to high altitudes. Circulation. 1963;27:1094–1100. doi: 10.1161/01.CIR.27.6.1094. [DOI] [PubMed] [Google Scholar]
  • 392.Saldana M., Arias-Stella J. Studies on the structure of the pulmonary trunk. III. The thickness of the media of the pulmonary trunk and ascending aorta in high altitude natives. Circulation. 1963;27:1101–1104. doi: 10.1161/01.CIR.27.6.1101. [DOI] [PubMed] [Google Scholar]
  • 393.Naeye R.L. Hypoxemia and pulmonary hypertension. Arch Pathol. 1961;71:447. [PubMed] [Google Scholar]
  • 394.Ahmed Q., Chung-Park M., Tomashefski J.F., Jr Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Hum Pathol. 1997;28:264–269. doi: 10.1016/S0046-8177(97)90122-2. [DOI] [PubMed] [Google Scholar]
  • 395.Arias-Stella J., Saldana M. The terminal portion of the pulmonary arterial tree in people native to high altitudes. Circulation. 1962;28:915–925. doi: 10.1161/01.CIR.28.5.915. [DOI] [PubMed] [Google Scholar]
  • 396.Naeye R.L. Pulmonary vascular changes with chronic unilateral pulmonary hypoxia. Circ Res. 1965;17:160–167. doi: 10.1161/01.RES.17.2.160. [DOI] [PubMed] [Google Scholar]
  • 397.Wagenvoort C.A., Wagenvoort N. Pulmonary veins in high-altitude residents: a morphometric study. Thorax. 1982;37:931–935. doi: 10.1136/thx.37.12.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 398.Davies G., Reid L. Effect of scoliosis on growth of alveoli and pulmonary arteries and on right ventricle. Arch Dis Child. 1971;46:623–632. doi: 10.1136/adc.46.249.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 399.Heath D., Edwards C., Harris P. Post-mortem size and structure of the human carotid body. Its relation to pulmonary disease and cardiac hypertrophy. Thorax. 1970;25:129–140. doi: 10.1136/thx.25.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 400.Lack E.E. Carotid body hypertrophy in patients with cystic fibrosis and cyanotic congenital heart disease. Hum Pathol. 1977;8:39–52. doi: 10.1016/S0046-8177(77)80064-6. [DOI] [PubMed] [Google Scholar]
  • 401.Saldana M.J., Salem L.E., Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol. 1973;4:251–263. doi: 10.1016/S0046-8177(73)80012-7. [DOI] [PubMed] [Google Scholar]
  • 402.Kennedy J.I., Fulmer J.D. Pulmonary hypertension in the interstitial lung diseases. Chest. 1985;87:558–559. doi: 10.1378/chest.87.5.558. [DOI] [PubMed] [Google Scholar]
  • 403.Heath D., Gillund T.D., Kay J.M., et al. Pulmonary vascular disease in honeycomb lung. J Pathol Bacteriol. 1968;95:423–430. doi: 10.1002/path.1700950212. [DOI] [PubMed] [Google Scholar]
  • 404.Enson Y., Thomas H.M., III, Bosken C.H., et al. Pulmonary hypertension in interstitial lung disease: relation of vascular resistance to abnormal lung structure. Trans Assoc Am Phys. 1975;88:248–255. [PubMed] [Google Scholar]
  • 405.Tomashefski J.F., Jr . Pulmonary pathology of the acute respiratory distress syndrome. Diffuse alveolar damage. In: Matthay M.A., editor. Acute respiratory distress syndrome. New York: Marcel Dekker; 2003. pp. 75–114. [Google Scholar]
  • 406.Tomashefski J.F., Jr, Davies P., Boggis L., et al. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol. 1983;112:112–126. [PMC free article] [PubMed] [Google Scholar]
  • 407.Zapol W.M., Snider M.T. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med. 1977;296:476–480. doi: 10.1056/NEJM197703032960903. [DOI] [PubMed] [Google Scholar]
  • 408.Greene R., Zapol W.M., Snider M.T., et al. Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis. 1981;124:593–601. doi: 10.1164/arrd.1981.124.5.593. [DOI] [PubMed] [Google Scholar]
  • 409.Barth P.J., Knoch M., Muller E., et al. Morphometry of parenchymal and vascular alterations in ARDS after extracorporeal carbon dioxide removal therapy (ECCO2-R-therapy) Path Res Pract. 1992;188:653–656. doi: 10.1016/S0344-0338(11)80074-9. [DOI] [PubMed] [Google Scholar]
  • 410.Wilkinson M., Langhorne C.A., Heath D., et al. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Quart J Med. 1988;249:65–85. [PubMed] [Google Scholar]
  • 411.Chaouat A., Bugnet A.S., Kadaoui N., et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–194. doi: 10.1164/rccm.200401-006OC. [DOI] [PubMed] [Google Scholar]
  • 412.Hicken P., Heath D., Brewer D.B., et al. The small pulmonary arteries in emphysema. J Pathol Bacteriol. 1965;90:107–114. doi: 10.1002/path.1700900111. [DOI] [PubMed] [Google Scholar]
  • 413.Naeye R.L., Greenberg D. Small pulmonary vessels in advanced pulmonary emphysema. Arch Pathol. 1974;97:216–220. [PubMed] [Google Scholar]
  • 414.Magee F., Wright J.L., Wiggs B.R., et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988;43:183–189. doi: 10.1136/thx.43.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 415.Hale K.A., Niewoehner D.E., Cosio M.H. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis. 1980;122:273–278. doi: 10.1164/arrd.1980.122.2.273. [DOI] [PubMed] [Google Scholar]
  • 416.Dunnill M.S. An assessment of the anatomical factor in cor pulmonale in emphysema. J Clin Pathol. 1961;14:246–258. doi: 10.1136/jcp.14.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 417.Bignon J., Khoury F., Even P., et al. Morphometric study in chronic obstructive bronchopulmonary disease. Am Rev Respir Dis. 1969;99:669–695. doi: 10.1164/arrd.1969.99.5.669. [DOI] [PubMed] [Google Scholar]
  • 418.Liebow A.A. The bronchopulmonary venous collateral circulation with special reference to emphysema. Am J Pathol. 1953;29:251–263. [PMC free article] [PubMed] [Google Scholar]

Articles from Dail and Hammar’s Pulmonary Pathology are provided here courtesy of Nature Publishing Group

RESOURCES